CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 1 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $199,000 | -43.9% | 47,245 | -33.7% | 0.00% | -100.0% |
Q1 2021 | $355,000 | +181.7% | 71,239 | +422.0% | 0.00% | – |
Q4 2019 | $126,000 | -58.7% | 13,648 | -45.9% | 0.00% | – |
Q1 2019 | $305,000 | -80.5% | 25,240 | -79.7% | 0.00% | -100.0% |
Q4 2018 | $1,561,000 | -56.9% | 124,394 | -49.0% | 0.00% | -33.3% |
Q3 2018 | $3,622,000 | -20.1% | 244,081 | -9.3% | 0.00% | -40.0% |
Q2 2018 | $4,531,000 | -49.0% | 269,188 | -30.6% | 0.01% | -50.0% |
Q1 2018 | $8,879,000 | +110.9% | 387,748 | +138.3% | 0.01% | +150.0% |
Q4 2017 | $4,210,000 | +2651.6% | 162,739 | +976.0% | 0.00% | – |
Q3 2016 | $153,000 | -63.7% | 15,125 | -59.6% | 0.00% | -100.0% |
Q2 2016 | $421,000 | -53.8% | 37,469 | -43.9% | 0.00% | -50.0% |
Q1 2016 | $912,000 | -55.6% | 66,786 | -38.3% | 0.00% | -50.0% |
Q4 2015 | $2,054,000 | -30.8% | 108,276 | -31.5% | 0.00% | -33.3% |
Q3 2015 | $2,967,000 | +532.6% | 158,081 | +401.9% | 0.01% | +500.0% |
Q2 2015 | $469,000 | – | 31,499 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 4,420,349 | $25,814,838 | 3.96% |
Parkman Healthcare Partners LLC | 1,203,484 | $7,028,347 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 1,002,783 | $5,856,253 | 1.26% |
TANG CAPITAL MANAGEMENT LLC | 1,150,000 | $6,716,000 | 0.98% |
BVF INC/IL | 3,629,000 | $21,193,360 | 0.89% |
Nantahala Capital Management | 1,732,388 | $10,117,146 | 0.66% |
AWM Investment Company, Inc. | 666,661 | $3,893,300 | 0.56% |
INGALLS & SNYDER LLC | 1,295,833 | $7,568 | 0.41% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 200,800 | $1,172,672 | 0.36% |
Kensington Investment Counsel, LLC | 58,599 | $342,218 | 0.27% |